Zara Ali

A quantitative proteomics approach identifies ETV6 and IKZF1 as new regulators of an ERG-driven transcriptional network

D. Beck, J. Wong, Yizhou Huang, 2016, Nucleic acids research.

CD30 and ALK combination therapy has high therapeutic potency in RANBP2-ALK-rearranged epithelioid inflammatory myofibroblastic sarcoma

K. MacKenzie, J. Fletcher, T. Trahair, 2020, British Journal of Cancer.

DKC1 is a transcriptional target of GATA1 and drives upregulation of telomerase activity in normal human erythroblasts

H. Pickett, J. Pimanda, K. MacKenzie, 2019, Haematologica.

Integrative Genomics Identifies the Molecular Basis of Resistance to Azacitidine Therapy in Myelodysplastic Syndromes.

Susan R. Wilson, P. Campbell, P. Woll, 2017, Cell reports.

Protocol for the Stimulating β3-Adrenergic Receptors for Peripheral Artery Disease (STAR-PAD) trial: a double-blinded, randomised, placebo-controlled study evaluating the effects of mirabegron on functional performance in patients with peripheral arterial disease

A. Keech, S. Grieve, G. Figtree, 2021, BMJ Open.